Physician profile
George J Ko
NPI 1205890514
$28,189.35
in general payments reported to CMS, 2019-2025
21 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $1,843 · 2021: $13K · 2022: $8,432 · 2023: $4,387 · 2024: $172 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,211 · Food and Beverage: $669.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,211.06 |
| Food and Beverage | $668.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $24,380.66 | 2021-2023 | Visucam Fundus Cameras |
| Carl Zeiss Meditec, INC. | $1,810.10 | 2019-2020 | |
| Notal Vision, INC. | $498.44 | 2021-2022 | |
| Genentech USA, INC. | $407.64 | 2022-2025 | Vabysmo |
| Alimera Sciences, INC. | $353.33 | 2019-2023 | Iluvien |
| Abbvie INC. | $185.89 | 2022-2025 | |
| Astellas Pharma US INC | $83.49 | 2024-2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $66.17 | 2019-2023 | Eylea |
| Bausch & Lomb Americas INC. | $57.64 | 2022-2023 | Vyzulta |
| Sun Pharmaceutical Industries INC. | $44.33 | 2019 | |
| Eyepoint US, INC. | $40.82 | 2019-2022 | |
| Harrow Eye, LLC | $39.97 | 2025 | Iheezo |
| Apellis Pharmaceuticals, INC. | $36.47 | 2022-2024 | Syfovre |
| Kala Pharmaceuticals, INC. | $35.48 | 2019 | |
| Thrombogenics, INC. | $23.65 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $23.35 | 2023 | |
| Spark Therapeutics, INC. | $23.09 | 2019 | |
| Biogen, INC. | $22.78 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.49 | 2019 | |
| Mallinckrodt Enterprises LLC | $18.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Ko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.